Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Boston Scientific (NYSE: BSX) today announced that the first implants of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device – the latest...
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray 27th Annual Healthcare Conference on December 1, in New...
Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a...
Boston Scientific (NYSE: BSX) this week announced the start of the Boston Scientific Connected Patient Challenge, an open innovation contest designed ...
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent ...
Tanto el trabajo como la vida social y familiar se ven afectados por el asma grave; muchos pacientes refieren sentir ansiedad, depresión y...
La vita professionale, sociale e familiare è condizionata dall'asma grave; molti pazienti riferiscono anche sensazioni di ansia, depressione e...
L'asthme sévère retentit sur la vie professionnelle, sociale et familiale, et de nombreuses personnes déclarent qu'elles souffrent également...
Schweres Asthma beeinträchtigt Arbeits-, Sozial- und Familienleben, viele Patienten berichten von Angstgefühlen, Depressionen und Isolation Boston...
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific (NYSE: BSX) Eluvia™ Drug-Eluting Vascular Stent...
Boston Scientific (NYSE: BSX) has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable...
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™...
Boston Scientific (NYSE: BSX) reported positive, long-term data from the EVOLVE Trial of the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer...
Boston Scientific (NYSE: BSX) announces the signing of two strategic agreements to advance the company's efforts to bring value based solutions aimed ...
New retrospective data evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate...
In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific (NYSE: BSX) SYNERGY™ Everolimus-Eluting...
New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus™ Valve System continue to demonstrate strong performance as a...
Boston Scientific unterstreicht damit seinen Einsatz für globale Weiterbildung und Innovation PARIS, 15.Mai 2014 - Boston Scientific Corporation...
Boston Scientific Corporation (NYSE:BSX) ha celebrado la inauguración de unas nuevas instalaciones dedicadas a la formación en la técnica endoscópica ...
Boston Scientific renforce à l'échelle mondiale son engagement en termes de formation et d'innovation Boston Scientific Corporation (NYSE : BSX) a...
Boston Scientific refuerza su compromiso con la formación y la innovación a escala mundial Boston Scientific Corporation (NYSE:BSX) ha celebrado la...
Boston Scientific rafforza il suo impegno nell'educazione e nell'innovazione a livello globale Boston Scientific Corporation (NYSE:BSX) ha celebrato...
Une régurgitation paravalvulaire aortique modérée rapportée chez 1.1% des patients uniquement Aucun cas de régurgitation paravalvulaire sévère Boston ...
Nur bei 1,1% der Patienten kommt es zu mäßiggradiger paravalvulärer Regurgitation; schwere Fälle traten nicht auf Im Verlauf der fortgesetzten...
Los datos del estudio EVOLVE, presentados hoy en EuroPCR 2014, muestran además un excelente perfil de seguridad. Boston Scientific Corporation (NYSE: ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.